Clinical TrialsSearch results
Number of results: 328
Completed
- Interventional, exploratory, open-label trial of Lu AF28996 in Japanese men and women with Parkinson's disease
- Parkinson's disease
- Yazawa Masanari
- 2023-08-12
Completed
- Randomized trial of Gorei-san enteroclysis
- Infectious gastroenteritis
- Niino Ryoji
- 2019-03-22
Completed
- Safety verification of robot-assisted laparoscopic resection for transverse colon cancer
- Transverse colon cancer
- Ogi Yusuke
- 2022-01-09
Completed
- Study of BUT measurement method
- Dry eye disease
- Sakane Yuri
- 2022-05-30
Recruiting
- A phase II randomized trial of adjuvant chemotherapy for the patients completely resected pathological stage IB(T>5cm), II, IIIA Non Small Cell Lung Cancer comparing S-1 / S-1 with CDDP
- non-small cell lung cancer
- Kyushu University,Graduate School of Medical Science,Department of Surgery and Science
- 2009-03-12
Recruiting
- A Phase III, Randomised, Double-blind, Placebo-controlled, Multicentre, International Study of Durvalumab Plus Domvanalimab(AB154) in Participants With Locally Advanced (Stage III), Unresectable Non-small Cell Lung Cancer Whose Disease Has Not Progressed Following Definitive Platinum-based Concurrent Chemoradiation Therapy
- Non-Small Cell Lung Cancer
- Yamaji Shigeyuki
- 2022-03-23
Recruiting
- A Randomised phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advaneced or recurrent gastric cancer resistant to S-1
- Gastric Cancer
- ECRIN
- 2009-10-01
Recruiting
- A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy
- Breast Cancer
- Inoguchi Akihiro
- 2022-06-09
Recruiting
- A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers (HERIZON-GEA-01)
- advanced or metastatic GEA, including gastric, GEJ, and esophageal adenocarcinomas.
- Sakanishi Ryuichi
- 2023-06-19
Recruiting
- An Expanded Access Program for belantamab mafodotin in Patients with Relapsed/Refractory Multiple Myeloma
- Multiple Myeloma
- Ishibashi Hideyasu
- 2022-02-15